2017
DOI: 10.1093/bja/aex163
|View full text |Cite
|
Sign up to set email alerts
|

Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148® on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial

Abstract: Australian New Zealand Clinical Trials Registry: ACTRN12612000023853.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
52
2
4

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(61 citation statements)
references
References 30 publications
3
52
2
4
Order By: Relevance
“…Clinicians tend to use saline in diabetic patients and patients with renal dysfunction to avoid hyperkalemiaalthough patients given saline actually have more hyperkalemia, hyperchloremia, and acidosis. 27 Saline is presumed to be safe when mixed with packed erythrocytes. However, lactated Ringer's solution can also be safely mixed with packed erythrocytes without provoking clot formation.…”
Section: Discussionmentioning
confidence: 99%
“…Clinicians tend to use saline in diabetic patients and patients with renal dysfunction to avoid hyperkalemiaalthough patients given saline actually have more hyperkalemia, hyperchloremia, and acidosis. 27 Saline is presumed to be safe when mixed with packed erythrocytes. However, lactated Ringer's solution can also be safely mixed with packed erythrocytes without provoking clot formation.…”
Section: Discussionmentioning
confidence: 99%
“…Elomel Isoton, which has been used in a trial of deceased donor transplant recipients, is similar to Plasmalyte, except that acetate is the sole buffer (Plasmalyte contains both acetate and gluconate buffers); however, it is not currently licensed in Australia and New Zealand. Plasmalyte is licensed in Australia, New Zealand, and many other countries, is readily available and already in use at many centers, and was recently evaluated for safety and potential efficacy in a small trial involving deceased donor kidney transplant recipients [29]. Thus, Plasmalyte was selected as the experimental low-chloride crystalloid fluid therapy for this trial.…”
Section: Interventions Explanation For the Choice Of Comparators {6b}mentioning
confidence: 99%
“…The effect size, or minimum clinically important difference, was determined by considering that a relative risk (RR) reduction of approximately 25% (RR of 0.75) for the incidence of the primary outcome would be both clinically meaningful and within the range of biological plausibility for the association between DGF and Plasmalyte versus 0.9% saline. The latter is based on trends observed in (1) the Weinberg trial [29]: RR of dialysis within 48 h posttransplant of 0.78 (95% confidence interval (CI) 0.47 to 1.28) and (2) a recently published before-and-after nonrandomized interventional study [39]: RR for dialysis within 48 h of 0.3 (95% CI 0.10 to 0.97; adjusted odds ratio 0.14; 95% CI 0.03 to 0.48), as the most current and relevant data available. A sample size of 722 participants (361 per group) will have 80% power at a 5% two-sided significance level to show an estimated absolute difference between the groups of 10% (41% versus 31%), with an estimated overall incidence of DGF of 36% and RR for Plasmalyte versus 0.9% saline of 0.76.…”
Section: Sample Size {14}mentioning
confidence: 99%
“…The finding of significantly more hyperkalemia with 0.9% saline than lactated Ringers (containing 4 mmol/l potassium) was corroborated in two further studies in adult kidney transplant recipients [ 60 , 61 ]. PlasmaLyte (containing 5 mmol/l potassium) has also been shown to reduce the risk of hyperkalemia relative to potassium-free 0.9% saline in adults with end-stage kidney disease undergoing transplantation [ 62 , 63 ]. Although no pediatric data are available, these findings are noteworthy because pediatric transplant recipients receive large volumes of intravenous crystalloid to maintain allograft perfusion perioperatively [ 64 ].…”
Section: The Case For Abandoning 09% Salinementioning
confidence: 99%